12-48914559-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7
The NM_033124.5(CCDC65):c.456G>A(p.Glu152=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000667 in 1,614,018 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00062 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 1 hom. )
Consequence
CCDC65
NM_033124.5 synonymous
NM_033124.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
CCDC65 (HGNC:29937): (coiled-coil domain containing 65) This gene encodes a sperm tail protein that is highly expressed in adult testis, spermatocytes and spermatids. The protein plays a critical role in the assembly of the nexin-dynein regulatory complex. Mutations in this gene result in primary ciliary dyskinesia. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 12-48914559-G-A is Benign according to our data. Variant chr12-48914559-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 416604.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.06 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC65 | NM_033124.5 | c.456G>A | p.Glu152= | synonymous_variant | 3/8 | ENST00000320516.5 | NP_149115.2 | |
CCDC65 | NM_001286957.2 | c.27G>A | p.Glu9= | synonymous_variant | 3/8 | NP_001273886.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC65 | ENST00000320516.5 | c.456G>A | p.Glu152= | synonymous_variant | 3/8 | 1 | NM_033124.5 | ENSP00000312706 | P2 | |
CCDC65 | ENST00000266984.9 | c.456G>A | p.Glu152= | synonymous_variant | 3/9 | 5 | ENSP00000266984 | A2 | ||
CCDC65 | ENST00000552942.5 | c.301-3716G>A | intron_variant | 5 | ENSP00000446569 | |||||
CCDC65 | ENST00000547861.5 | c.*287G>A | 3_prime_UTR_variant, NMD_transcript_variant | 3/8 | 2 | ENSP00000447157 |
Frequencies
GnomAD3 genomes AF: 0.000624 AC: 95AN: 152206Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
95
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000805 AC: 202AN: 251052Hom.: 1 AF XY: 0.000810 AC XY: 110AN XY: 135726
GnomAD3 exomes
AF:
AC:
202
AN:
251052
Hom.:
AF XY:
AC XY:
110
AN XY:
135726
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000671 AC: 981AN: 1461694Hom.: 1 Cov.: 32 AF XY: 0.000644 AC XY: 468AN XY: 727170
GnomAD4 exome
AF:
AC:
981
AN:
1461694
Hom.:
Cov.:
32
AF XY:
AC XY:
468
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000624 AC: 95AN: 152324Hom.: 1 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74482
GnomAD4 genome
AF:
AC:
95
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 27 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 16, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at